Research Areas
Biography and Research Information
OverviewAI-generated summary
Ravi P. Cholia's research investigates molecular mechanisms underlying glioblastoma and the therapeutic potential of phytochemicals and dietary compounds. His work has focused on the role of pyruvate kinase (PKM2) in glioblastoma multiforme and the neuroprotective effects of nicotinamide riboside. In studies on glioblastoma, Cholia has explored its cellular characteristics and potential therapeutic targets. His recent publication on nicotinamide riboside demonstrates its ability to alleviate cisplatin-induced peripheral neuropathy through SIRT2 activation. Cholia has a h-index of 7 with 10 total publications and 324 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Ratan Sadhukhan, Mousumi Patra, Fen Xia, and Wuying Du.
Metrics
- h-index: 7
- Publications: 10
- Citations: 327
Selected Publications
-
Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation (2022)
-
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation (2022)
-
A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme (2021)
Grants & Funding
Collaboration Network
Top Collaborators
- A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme
- A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme
- A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme
- A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
Similar Researchers
Based on overlapping research topics